Home > Cardiology > ACC/WCC 2020 > Atrial Fibrillation/Acute Coronary Syndrome > LAAO Watchman registry data positive

LAAO Watchman registry data positive

Presented By
Prof. James V. Freeman, Yale University School of Medicine, USA
Conference
ACC 2020
Real-world evidence from the National Cardiovascular Data Registry (NCDR) Left Atrial Appendage Occlusion (LAAO) registry of patients implanted percutaneously with the Watchman device reveals a high implant success rate in addition to a low rate of in-hospital complications. Dr James Freeman (Yale University School of Medicine, USA) presented the observational, non-randomised, post-approval analysis from the registry of periprocedural outcomes of the Watchman LAAO device, which includes data from >38,000 patients, [1]. The study was simultaneously published by theĀ Journal of the American College of CardiologyĀ [2]. The approval of LAAO to prevent stroke in patients with atrial fibrillation (AF) was established in 2015, based on 2 randomised trials, yet post-approval clinical data are limited [3,4]. To qualify for Medicare reimbursement in the USA, hospitals have been required to report all Watchman device procedures to the NCDR ...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on